University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

Get This Resource

English: PDF [168K]


This update from the World Health Organization is on programmatic implementation of PMTCT. The update suggests that "Option B+," or providing triple antiretroviral therapy for pregnant women in antenatal clinics with the intention of continuing therapy for life, is a potentially attractive approach that should be considered by policymakers and implementers.

Publisher: World Health Organization
Language: English
Format: PDF
Region: Global
Audiences: Doctors/Physicians, Physician's Assistants/Nurse Practitioners, Policymakers, Program Managers
Topic Areas: Antiretroviral Treatment & Complications, Perinatal Interventions
Resource Type: Program Best Practices